Home » Archive

Marketwire, News, NYSE:PFE, Syndication »

Lpath Receives First U.S. Patent for Anti-LPA Antibody, Lpathomab

Posted by Mary Canady April 25th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 25, 2012) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that it has been issued a key patent prote…

More...

Marketwire, News, Syndication »

Gene Ray, Founder of $2.6 Billion Titan Corp, Invests in Medistem’s ERC Technology and Joins Advisory Board

Posted by Mary Canady April 25th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 25, 2012) – Medistem Inc. (PINKSHEETS: MEDS) announced Dr. Gene Ray, founder of $2.6 Billion Titan Corp, has invested in and joined the Advisory Board for Medistem Inc. Dr. Ray is a Ph.D in Theoretical Physics, Inven…

More...

Marketwire, News, Syndication »

AstraZeneca to Acquire Ardea Biosciences for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout

Posted by Mary Canady April 22nd, 2012 .
No Comments

SAN DIEGO,CA–(Marketwire – Apr 23, 2012) – AstraZeneca and Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced that they have entered into a definitive merger agreement, pursuant to which AstraZeneca will acquire Ardea, a San Diego, California-b…

More...

Marketwire, News, Syndication »

Quidel Receives CLIA Waiver for Its Sofia(TM) Analyzer and Sofia Influenza A+B Fluorescent Immunoassay (FIA)

Posted by Mary Canady April 20th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 20, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cell-based virology assays, announced today that it has received Clinical Laboratory Improvement Amendments …

More...

Marketwire, News, Syndication »

La Jolla Pharmaceutical Company Announces Development Programs for Lead Product, GCS-100

Posted by Mary Canady April 16th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 16, 2012) – La Jolla Pharmaceutical Company (OTCQB: LJPC) (PINKSHEETS: LJPC) today announced initial product development plans for advancing GCS-100, its first-in-class inhibitor of galectin-3.
On January 20, …

More...

Marketwire, News, Syndication »

Quidel to Hold First Quarter 2012 Financial Results Conference Call on April 25, 2012

Posted by Mary Canady April 13th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 13, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release first quarter 2012 financial results after market close on Wedn…

More...

Marketwire, News, Syndication »

ISTA Pharmaceuticals, Inc. (ISTA) Investor Lawsuit Against Buyout Announced by Shareholders Foundation

Posted by Mary Canady April 3rd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 3, 2012) – The Shareholders Foundation, Inc. announces that an investor filed a lawsuit in State Court for current stockholders of ISTA Pharmaceuticals, Inc. (ISTA) against directors of ISTA Pharmaceuticals, Inc. in a…

More...

Marketwire, News, Syndication »

Medistem Collaborates With Loma Linda University on Treatment of Traumatic Brain Injury Using Endometrial Regenerative Cells (ERC)

Posted by Mary Canady April 2nd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 3, 2012) – Medistem Inc. (PINKSHEETS: MEDS) announced today collaboration with Dr. C.S. Chen, Head of the Division of Oncology and Hematology of Loma Linda University and Dr. Anatol Manaenko, Zhang Neuroscience Resea…

More...

Marketwire, News, Syndication »

Quidel Receives CE Mark for Its Direct Specimen Rapid PCR Test for Toxigenic Clostridium Difficile

Posted by Mary Canady April 2nd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 2, 2012) – Quidel Corporation (NASDAQ: QDEL) announced today that it received CE mark for the Quidel MolecularT Direct C. difficile Tox A/B assay for the detection of toxigenic Clostridium difficile bacterial DNA. C….

More...

Headline, SDBN Blog, SDBN Events »

Brewing Science: Improving Science Communication with ASBMB April 23rd At Mission Brewery

Posted by Mary Canady March 30th, 2012 .
No Comments

In April we’re teaming up with the American Society for Biochemistry and Molecular Biology (ASBMB) to host an event at Mission Brewery downtown during the big Experimental Biology conference. You may know we are big proponents of science communication because it helps researchers with their careers, funding, and connecting with other scientists.
The event will feature bloggers, reporters, industry professionals, public speaking experts, and policy makers, all who will be available to help you improve your science communication skills. We’ll have some fun contests to help you meet people, and there …

More...